DZ3310A1 - Inhibiteurs de l'echangeur sodium-hydrogene de type 1 - Google Patents

Inhibiteurs de l'echangeur sodium-hydrogene de type 1

Info

Publication number
DZ3310A1
DZ3310A1 DZ013310A DZ013310A DZ3310A1 DZ 3310 A1 DZ3310 A1 DZ 3310A1 DZ 013310 A DZ013310 A DZ 013310A DZ 013310 A DZ013310 A DZ 013310A DZ 3310 A1 DZ3310 A1 DZ 3310A1
Authority
DZ
Algeria
Prior art keywords
nhe
inhibitor
sodium
exchanger type
hydrogen exchanger
Prior art date
Application number
DZ013310A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of DZ3310A1 publication Critical patent/DZ3310A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ013310A 2000-04-28 2001-02-28 Inhibiteurs de l'echangeur sodium-hydrogene de type 1 DZ3310A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (fr) 2000-04-28 2001-02-28 Inhibiteurs de l'echangeur sodium-hydrogene de type 1

Publications (1)

Publication Number Publication Date
DZ3310A1 true DZ3310A1 (fr) 2001-11-07

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013310A DZ3310A1 (fr) 2000-04-28 2001-02-28 Inhibiteurs de l'echangeur sodium-hydrogene de type 1

Country Status (40)

Country Link
EP (1) EP1276737A1 (fr)
JP (1) JP2003531900A (fr)
KR (1) KR20020093079A (fr)
CN (1) CN1225466C (fr)
AP (1) AP2002002651A0 (fr)
AR (1) AR028375A1 (fr)
AU (1) AU2001235896A1 (fr)
BG (1) BG107139A (fr)
BR (1) BR0110268A (fr)
CA (1) CA2407535A1 (fr)
CO (1) CO5221125A1 (fr)
CR (1) CR6797A (fr)
CZ (1) CZ20023408A3 (fr)
DZ (1) DZ3310A1 (fr)
EA (1) EA004882B1 (fr)
EE (1) EE200200615A (fr)
GT (1) GT200100064A (fr)
HN (1) HN2001000042A (fr)
HR (1) HRP20020851A2 (fr)
HU (1) HUP0300651A2 (fr)
IL (1) IL152075A0 (fr)
IS (2) IS6567A (fr)
MA (1) MA26897A1 (fr)
MX (1) MXPA02010600A (fr)
MY (1) MY133842A (fr)
NO (1) NO20025132L (fr)
NZ (1) NZ521348A (fr)
OA (1) OA12256A (fr)
PA (1) PA8513301A1 (fr)
PE (1) PE20011270A1 (fr)
PL (1) PL357765A1 (fr)
SK (1) SK14872002A3 (fr)
SV (1) SV2002000418A (fr)
TN (1) TNSN01065A1 (fr)
TR (1) TR200202439T2 (fr)
UA (1) UA73348C2 (fr)
UY (1) UY26680A1 (fr)
WO (1) WO2001083470A1 (fr)
YU (1) YU79602A (fr)
ZA (1) ZA200208605B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355899A1 (fr) * 2001-01-31 2003-10-29 Pfizer Products Inc. Ethanolats d'inhibiteur de type 1 d'echangeur sodium-hydrogene
CA2469305A1 (fr) * 2001-12-19 2003-06-26 Frank Robert Busch Methodes de preparation d'inhibiteurs de type 1 d'echangeurs de sodium-hydrogene
WO2003092694A1 (fr) * 2002-05-02 2003-11-13 Pfizer Products Inc. Traitement du diabete et de complications diabetiques a l'aide d'inhibiteurs nhe-1
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46200A (sh) * 1998-02-27 2003-02-28 Pfizer Products Inc. N-(supstituisani peto-članog di-ili triaza dinezasićenog prstena)karbonil/guanidin derivati za tretiranje ishemije

Also Published As

Publication number Publication date
AP2002002651A0 (en) 2002-12-31
BR0110268A (pt) 2003-12-30
BG107139A (bg) 2003-07-31
HRP20020851A2 (en) 2005-02-28
MY133842A (en) 2007-11-30
EA004882B1 (ru) 2004-08-26
JP2003531900A (ja) 2003-10-28
YU79602A (en) 2006-05-25
GT200100064A (es) 2002-03-22
IL152075A0 (en) 2003-05-29
CR6797A (es) 2004-05-17
MXPA02010600A (es) 2003-03-10
PL357765A1 (en) 2004-07-26
CN1426404A (zh) 2003-06-25
IS6567A (is) 2002-09-24
AU2001235896A1 (en) 2001-11-12
CO5221125A1 (es) 2002-11-28
MA26897A1 (fr) 2004-12-20
NO20025132D0 (no) 2002-10-25
PA8513301A1 (es) 2003-09-05
CZ20023408A3 (cs) 2004-01-14
UY26680A1 (es) 2001-12-28
EA200201023A1 (ru) 2003-02-27
AR028375A1 (es) 2003-05-07
NZ521348A (en) 2004-09-24
EP1276737A1 (fr) 2003-01-22
CA2407535A1 (fr) 2001-11-08
NO20025132L (no) 2002-12-12
PE20011270A1 (es) 2001-12-12
KR20020093079A (ko) 2002-12-12
SV2002000418A (es) 2002-07-03
SK14872002A3 (sk) 2004-03-02
UA73348C2 (en) 2005-07-15
CN1225466C (zh) 2005-11-02
HN2001000042A (es) 2001-07-09
TR200202439T2 (tr) 2003-02-21
WO2001083470A1 (fr) 2001-11-08
HUP0300651A2 (hu) 2003-07-28
IS6588A (is) 2002-10-21
ZA200208605B (en) 2003-10-24
EE200200615A (et) 2004-04-15
OA12256A (en) 2003-11-06
TNSN01065A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
PL349872A1 (en) Heat exchanger
EP1347260A4 (fr) Echangeur thermique
DE69911131D1 (de) Wärmetauscher
EP1249586A4 (fr) Echangeurs de chaleur
EP1347259A4 (fr) Echangeur de chaleur
IL152075A0 (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
EP1136783A4 (fr) Echangeur de chaleur
GB2367355B (en) A heat exchanger
ZA200203295B (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
GB0031183D0 (en) Heat exchanger
ZA200006007B (en) Method for preparing sodium-hydrogen exchanger type 1 inhibitor.
GB9926629D0 (en) Heat exchangers
GB0026085D0 (en) Heat exchanger system
GB2367886B (en) Heat exchanger
GB0009380D0 (en) Heat exchanger
GB0012414D0 (en) Heat exchanger
GB0011633D0 (en) Heat exchangers
GB0026297D0 (en) Heat exchangers
GB0004817D0 (en) Heat exchanger
GB0013054D0 (en) Heat exchanger
PL340103A1 (en) Heat exchanger
GB0009182D0 (en) Heat exchanger
GB0006080D0 (en) Heat exchanger
EP1055095A4 (fr) Echangeur de chaleur
EP1111322A4 (fr) Echangeur thermique